Raffaella Buzzetti

Pubblicazioni

Titolo Pubblicato in Anno
IFN-α neutralizing antibodies distinguish LADA from early-onset type 1 diabetes THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2025
Residual C-peptide secretion is associated with better CGM-metrics in adults with short-lasting type 1 diabetes DIABETES RESEARCH AND CLINICAL PRACTICE 2025
Cardiac autonomic neuropathy is associated with ectopic fat distribution in autoimmune but not in type 2 diabetes CARDIOVASCULAR DIABETOLOGY 2025
Searching the Crystal Ball for Tailored GLP‐1 Receptor Agonists Treatment in Type 2 Diabetes and Obesity DIABETES/METABOLISM RESEARCH AND REVIEWS 2025
Osteocalcin is inversely associated with worse adipose tissue distribution and cardiovascular risk in autoimmune diabetes DIABETES RESEARCH AND CLINICAL PRACTICE 2025
Preferences, Expectations and Attitudes on Basal Insulin from Patient–Physician–Payer Perspective: A Multi-stakeholder Survey by the Italian Diabetes Society (ITA4P Study) DIABETES THERAPY 2025
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study DIABETES, OBESITY AND METABOLISM 2024
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk THE LANCET REGIONAL HEALTH. EUROPE 2024
IDegLira for the real-world treatment of type 2 diabetes in Italy. Final results from the REX observational study DIABETES, OBESITY AND METABOLISM 2024
Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes EXPERT OPINION ON INVESTIGATIONAL DRUGS 2024
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk THE LANCET REGIONAL HEALTH. EUROPE 2024
LADA 30th anniversary: A growing form of diabetes with persistent unresolved questions DIABETES/METABOLISM RESEARCH AND REVIEWS 2024
No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study CLINICAL THERAPEUTICS 2024
Open questions on basal insulin therapy in T2D: a Delphi consensus ACTA DIABETOLOGICA 2024
Improved HbA1c and body weight in GADA-positive individuals treated with tirzepatide: A post hoc analysis of SURPASS THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2024
Correction: An updated algorithm for an effective choice of continuous glucose monitoring for people with insulin-treated diabetes ENDOCRINE 2024
Deterioration of Vestibular Motion Perception: A Risk Factor for Postural Instability and Falls in Elderly With Type 2 Diabetes DIABETES/METABOLISM RESEARCH AND REVIEWS 2024
Type 2 diabetes in children and adolescents: Challenges for treatment and potential solutions DIABETES RESEARCH AND CLINICAL PRACTICE 2024
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes DIABETES/METABOLISM RESEARCH AND REVIEWS 2023
Impact of baseline kidney function on the effects of sodium-glucose co-transporter-2 inhibitors on kidney and heart failure outcomes: A systematic review and meta-analysis of randomized controlled trials DIABETES, OBESITY AND METABOLISM 2023

Progetti di Ricerca

Gruppi di ricerca - Responsabile

Intervento farmacologico inibente la differenziazione delle cellule mieloidi verso un fenotipo calcificante
Slowly progressive autoimmune diabetes: a clinical model for novel pathways of ß-cell protection
Molecular and pathophysiological heterogeneity of autoimmune diabetes: implications for precision medicine
Synergies anchoring to gravity (SynErg): a novel test to diagnose risk of falls in type 2 diabetes patients

Laboratori di ricerca

Diabetologia e Malattie Metaboliche

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma